Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 0.33 |
| ▸ | F3 | P13726 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11165276 | 0.78 | ALDH1A1 (0.39) | MEN1KMT2A | |
| SCHEMBL1523079 | 0.77 | TSHR (0.46) | ELANEMEN1KMT2A | |
| SCHEMBL11162267 | 0.76 | PIM1 (0.37) | ELANEMEN1KMT2A | |
| SCHEMBL11156065 | 0.71 | PDE5A (0.47) | MEN1KMT2A | |
| SCHEMBL1227465 | 0.64 | EEF2K (0.35) | MEN1KMT2A | |
| SCHEMBL11168065 | 0.62 | ADORA1 (0.41) | ELANEKMT2A | |
| SCHEMBL12639123 | 0.62 | MEN1 (0.39) | MEN1KMT2A | |
| SCHEMBL11158214 | 0.61 | ADORA2A (0.40) | ELANEMEN1KMT2A | |
| SCHEMBL11495935 | 0.61 | ADORA1 (0.50) | ELANEMEN1KMT2A | |
| SCHEMBL6801181 | 0.60 | CDK4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2361913-A1 | Anti-infective agents | Abbott Laboratories (US) | 2011-08-31 | — | — | EP | disclosed |
| EP-1560827-B1 | ANTI-INFECTIVE AGENTS | ABBOTT LAB (US) | 2010-12-29 | — | — | EP | disclosed |
| US-20050075331-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2005-04-07 | — | — | US | disclosed |
| US-20040162285-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2004-08-19 | — | — | US | disclosed |
| US-20040097492-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2004-05-20 | — | — | US | disclosed |
| US-20040087577-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097492-A1 | Anti-infective agents | POLR1C, RPL5, POLB | F7 1423/4885F3 1527/4885ELANE 143/4885 |
| US-20040162285-A1 | Anti-infective agents | POLR1C, RPL5, POLB | F7 1423/4885F3 1527/4885ELANE 143/4885 |
| US-20050075331-A1 | Anti-infective agents | RPL35, POLI, POLRMT | F7 2717/4885F3 1212/4885ELANE 89/4885 |
| US-20040087577-A1 | Anti-infective agents | POLR1C, RPL5, POLB | F7 1423/4885F3 1527/4885ELANE 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.